ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

New Staging System on Horizon for Head and Neck Cancers

by Thomas R. Collins • June 20, 2017

  • Tweet
  • Email
Print-Friendly Version

The American Joint Committee on Cancer (AJCC) has announced a new edition of its staging manual for head and neck cancers. The revisions include sweeping changes in the classifications of some head and neck cancers and are scheduled to go into effect on January 1, 2018.

You Might Also Like

  • New Staging System Proposed for HPV-Related Oropharyngeal Cancer
  • Panel Discusses Case Management of Head and Neck Cancers at 2016 TRIO Combined Sections Meeting
  • Salvage Surgery in Head and Neck Cancers
  • ‘Patient-Centered Approach’ Delivers High-Quality Care to Patients with Head and Neck Cancers
Explore This Issue
June 2017

Dennis Kraus, MD, director of the Center for Head and Neck Oncology at the New York Head and Neck Institute in New York City, reviewed the update during a panel session at the Annual Meeting of the Triological Society. The changes are most dramatic in mucosal melanoma, oropharyngeal cancer, cancer with an unknown primary, and cancer of the oral cavity, he said.

The panel discussion also touched on robotic surgery and on the role of checkpoint inhibitors in head and neck cancer.

Changes to Cancer Staging

A main driver of the changes to the AJCC system was the goal to make staging a better tool for communicating with patients about their survival prospects, he said. “The concept is that we want to give any individual the actual likelihood of survival for their cancer,” he said. Those drafting the changes also wanted to refine the staging so that there would be a similar number of patients in each group, or roughly 25% in each of the four stages, he said.

Colored scanning electron micrograph (SEM) of squamous cell carcinoma cells from a human mouth.

Colored scanning electron micrograph (SEM) of squamous cell carcinoma cells from a human mouth.
© CNRI / Science Source

Another goal in making the changes is to distinguish each subgroup’s survival rates from those above and below it, he said. The changes also strive for worldwide acceptance and are meant to be applicable regardless of the resources of a center or provider, Dr. Kraus added.

Oropharyngeal cancer: Dr. Kraus said this is the category that has been updated the most. “One of the most notable changes—not just in the head and neck changes, but literally in this entire 600-page tome—are the changes that have been made in oropharyx cancer,” he said. Under the new system, only patients with metastatic disease will be considered stage IV. That’s because, when looking at three-year overall survival, stages I through III were grouped together fairly tightly, with “almost no statistical significance,” he said.

He added that, under the previous edition of the staging manual, the majority of patients were classified as having stage IV disease. “There’s poor balance, there’s poor hazard discrimination, and this was a must-fix for the current group,” he said. “We’ve made the obvious changes. We’ve separated oropharynx from hypopharynx. We have separate staging both for clinical and pathologic staging. And, interestingly, it’s very similar to nasopharynx disease, which has some overlap.”

Pages: 1 2 3 4 5 | Single Page

Filed Under: Features Tagged With: cancer staging, cancer therapy, head and neck cancer, Triological Society annual meetingIssue: June 2017

You Might Also Like:

  • New Staging System Proposed for HPV-Related Oropharyngeal Cancer
  • Panel Discusses Case Management of Head and Neck Cancers at 2016 TRIO Combined Sections Meeting
  • Salvage Surgery in Head and Neck Cancers
  • ‘Patient-Centered Approach’ Delivers High-Quality Care to Patients with Head and Neck Cancers

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Why Virtual Grand Rounds May Be Here to Stay
    • Otolaryngologist Leverages His Love of Pinball into Second Business
    • These New Imaging Advances May Help to Protect Parathyroids
    • Is the Training and Cost of a Fellowship Worth It? Here’s What Otolaryngologists Say
    • Which Otologic Procedures Poses the Greatest Risk of Aerosol Generation?

Polls

Have you used 3D-printed materials in your otolaryngology practice?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.